Authors:
VENOOK AP
EGORIN MJ
ROSNER GL
BROWN TD
JAHAN TM
BATIST G
HOHL R
BUDMAN D
RATAIN MJ
KEARNS CM
SCHILSKY RL
Citation: Ap. Venook et al., PHASE-I AND PHARMACOKINETIC TRIAL OF PACLITAXEL IN PATIENTS WITH HEPATIC-DYSFUNCTION - CANCER AND LEUKEMIA GROUP-B-9264, Journal of clinical oncology, 16(5), 1998, pp. 1811-1819
Authors:
GLANTZ MJ
CHOY H
AKERLEY W
KEARNS CM
EGORIN MJ
RHODES CH
COLE BF
Citation: Mj. Glantz et al., WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE, Seminars in radiation oncology, 7(2), 1997, pp. 25-33
Citation: Cm. Kearns, PROCEEDINGS OF THE UNIVERSITY-OF-MARYLAND-CANCER-CENTER-CONFERENCE ONANTINEOPLASTICS, SEPTEMBER 27-28, 1996, SAN-FRANCISCO, CALIFORNIA - INTRODUCTION, Pharmacotherapy, 17(5), 1997, pp. 93-95
Authors:
KEARNS CM
CASS WA
SMOOT K
KRYSCIO R
GASH DM
Citation: Cm. Kearns et al., GDNF PROTECTION AGAINST 6-OHDA - TIME-DEPENDENCE AND REQUIREMENT FOR PROTEIN-SYNTHESIS, The Journal of neuroscience, 17(18), 1997, pp. 7111-7118
Citation: Cm. Kearns et Mj. Egorin, CONSIDERATIONS REGARDING THE LESS-THAN-EXPECTED THROMBOCYTOPENIA ENCOUNTERED WITH COMBINATION PACLITAXEL CARBOPLATIN CHEMOTHERAPY/, Seminars in oncology, 24(1), 1997, pp. 91-96
Authors:
GLANTZ MJ
CHOY H
KEARNS CM
COLE BF
MILLS P
ZUHOWSKI EG
SARIS S
RHODES CH
STOPA E
EGORIN MJ
Citation: Mj. Glantz et al., PHASE-I STUDY OF WEEKLY OUTPATIENT PACLITAXEL AND CONCURRENT CRANIAL IRRADIATION IN ADULTS WITH ASTROCYTOMAS, Journal of clinical oncology, 14(2), 1996, pp. 600-609
Citation: Mj. Egorin et al., PLASMA PHARMACOKINETICS, BIOAVAILABILITY, AND TISSUE DISTRIBUTION IN CD2F1 MICE OF HALOMON, AN ANTITUMOR HALOGENATED MONOTERPENE ISOLATED FROM THE RED ALGAE PORTIERIA-HORNEMANNII, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 51-60
Authors:
GLANTZ MJ
CHOY H
AKERLEY W
KEARNS CM
EGORIN MJ
RHODES CH
COLE BF
Citation: Mj. Glantz et al., WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE, Seminars in oncology, 23(6), 1996, pp. 128-135
Authors:
GLANTZ MJ
CHOY H
KEARNS CM
MILLS PC
WAHLBERG LU
ZUHOWSKI EG
CALABRESI P
EGORIN MJ
Citation: Mj. Glantz et al., PACLITAXEL DISPOSITION IN PLASMA AND CENTRAL NERVOUS SYSTEMS OF HUMANS AND RATS WITH BRAIN-TUMORS, Journal of the National Cancer Institute, 87(14), 1995, pp. 1077-1081
Authors:
GIANNI L
KEARNS CM
GIANI A
CAPRI G
VIGANO L
LOCATELLI A
BONADONNA G
EGORIN MJ
Citation: L. Gianni et al., NONLINEAR PHARMACOKINETICS AND METABOLISM OF PACLITAXEL AND ITS PHARMACOKINETIC PHARMACODYNAMIC RELATIONSHIPS IN HUMANS/, Journal of clinical oncology, 13(1), 1995, pp. 180-190
Authors:
GLANTZ MJ
CHOY H
KEARNS CM
AKERLEY W
EGORIN MJ
Citation: Mj. Glantz et al., WEEKLY, OUTPATIENT PACLITAXEL AND CONCURRENT CRANIAL IRRADIATION IN ADULTS WITH BRAIN-TUMORS - PRELIMINARY-RESULTS AND PROMISING DIRECTIONS, Seminars in oncology, 22(5), 1995, pp. 26-32
Citation: Ng. Hairston et Cm. Kearns, THE INTERACTION OF PHOTOPERIOD AND TEMPERATURE IN DIAPAUSE TIMING - ACOPEPOD EXAMPLE, The Biological bulletin, 189(1), 1995, pp. 42-48
Citation: Cm. Kearns et al., PHARMACOKINETICS OF CLADRIBINE (2-CHLORODEOXYADENOSINE) IN CHILDREN WITH ACUTE-LEUKEMIA, Cancer research, 54(5), 1994, pp. 1235-1239
Authors:
KEARNS CM
WANG WC
STUTE N
IHLE JN
EVANS WE
Citation: Cm. Kearns et al., DISPOSITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN CHILDREN WITH SEVERE CHRONIC NEUTROPENIA, The Journal of pediatrics, 123(3), 1993, pp. 471-479